Commons Sense

House of Commons · Adjournment Debate

Foetal Valproate Spectrum Disorder: Fatalities

07 December 2022 · 2 other contributors

Opened by Caroline Nokes Con Romsey and Southampton North

NHS

Summarised by AI from the official record, so it can contain mistakes.

At a glance

Caroline Nokes raised concerns about foetal valproate spectrum disorder: fatalities in the House of Commons. A government minister responded. Other MPs also contributed.

Key points

  • Caroline Nokes initiated a debate on foetal valproate spectrum disorder, highlighting fatal cases like Jake Aldcroft's, who died at age 21 due to complications from the disorder.
  • Nokes emphasized the need for better communication and prevention measures regarding the risks of sodium valproate during pregnancy.
  • The Minister, Maria Caulfield, acknowledged the issue and discussed efforts to strengthen the pregnancy prevention programme and support for those taking sodium valproate.

How the debate unfolded

MPs spoke in turn to share their views and ask questions. Here's what each person said.

Opened the debate

Caroline Nokes Con Romsey and Southampton North

The debate was initiated by Caroline Nokes to discuss the issue of foetal valproate syndrome, particularly highlighting its fatal consequences. She cited Jake Aldcroft's case, who died at age 21 due to complications from FVSD that he had as a result of his mother taking sodium valproate during pregnancy without proper warning or information about potential risks. Nokes emphasised the ongoing impact on families and the need for improved communication and prevention measures. She also raised concerns about the lack of implementation of certain recommendations made by the Cumberlege report, such as the establishment of an independent redress agency to address past harm caused by valproate.

Other contributors (2)
  • Jake Morris Lab Bootle

    The hon. Member highlighted that the illness can continue down generations and cause fear for affected families.

  • Christian Wakeford Ind Bury South

    Asked about redress and suggested meeting campaigners Emma Murphy and Janet Williams to discuss a potential scheme for compensation.

Government Response

The Minister, Maria Caulfield, acknowledged the importance of addressing the issue and reiterated the Government's commitment to ensuring that women are adequately informed about the risks associated with sodium valproate during pregnancy. She discussed ongoing efforts to strengthen the pregnancy prevention programme and ensure proper monitoring and support for those taking the medication. The Minister also mentioned her willingness to explore options for a redress scheme, though she noted that any decisions on such schemes would need to be made in consultation with the Chancellor of the Exchequer.

▸ Assessment & feedback
Summary accuracy